Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study.
about
Tumour necrosis factor-mediated macrophage activation in the target organ is critical for clinical manifestation of uveitisCurrent concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation.Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.Adverse effects of systemic immunosuppression in keratolimbal allograft.Mycophenolate mofetil for ocular inflammation.Risk of relapse in primary acute anterior uveitis.Ocular disease in patients with ANCA-positive vasculitisRisk of corticosteroid-induced hyperglycemia requiring medical therapy among patients with inflammatory eye diseases.Pharmacotherapy for uveitis: current management and emerging therapy.Challenges for synthesising data in a network of registries for systemic psoriasis therapies.Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study.Success with single-agent immunosuppression for multifocal choroidopathies.Review of Systemic Immunosuppression for Autoimmune UveitisOutcomes of birdshot chorioretinopathy treated with an intravitreal sustained-release fluocinolone acetonide-containing device.Response of pediatric uveitis to tumor necrosis factor-α inhibitors.Juvenile idiopathic arthritis-associated uveitis.Incidence of visual improvement in uveitis cases with visual impairment caused by macular edemaClinical trials in noninfectious uveitisRemission of Intermediate Uveitis: Incidence and Predictive FactorsStructural changes of the choroid in sarcoid- and tuberculosis-related granulomatous uveitis.Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, or Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid TrRisk of Ocular Hypertension in Adults with Noninfectious Uveitis.Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.Subconjunctival dexamethasone implant for non-necrotizing scleritisStatin use and ocular inflammatory disease risk.Serpiginous choroiditis and infectious multifocal serpiginoid choroiditisAre patients with inflammatory eye disease treated with systemic immunosuppressive therapy at increased risk of malignancy?Azathioprine for ocular inflammatory diseases.Pharmacotherapy of scleritis: current paradigms and future directions.A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial).Factors predictive of remission of new-onset anterior uveitis.Pharmacotherapy of uveitis.Road to remission: a comprehensive review of therapy in uveitis.The role of biologic agents in the management of non-infectious uveitis.Systematic review of anti-tumor necrosis factor-alpha therapy for treatment of immune-mediated uveitis.Practical guidelines for the use of steroid-sparing agents in the treatment of chronic pruritus.Overview and recent developments in the medical management of paediatric uveitis.Cataract surgery in patients with history of uveitis.Emerging drugs for the treatment of uveitis.Noninfectious immune-mediated uveitis and ocular inflammation.
P2860
Q24633598-1A474737-DF8B-4CB7-8CFB-9F9D042CE88BQ27693189-2E24815C-4A61-48FD-8034-7AC5F7833B2BQ30397454-42E6C09A-106E-480B-8964-48D1735ECA41Q30468406-94DFC93E-61F2-4632-AFEA-B947FC08DCF4Q33521396-3C3FCA92-06FC-4A61-8AB1-1749C5ED5CCDQ33934732-99C465BF-2922-4340-A46F-C12B21EDA8A6Q34102383-03EB7759-99DF-4474-BE1B-CEEC078B658FQ34224273-733C62D6-BD55-46D4-AAC7-E40DEE49DA4FQ34274075-0674576A-1324-4288-B423-3690EF38486AQ34296816-91FD6B2A-AA1C-4932-B2CC-3DA2048CACFEQ34444734-AD39DC2A-F3EE-471E-A0DD-A93F47E9EC0EQ34623981-E67A21C9-140C-4BFC-863E-38E4F3AC0FE5Q34627012-DD783C74-EBC6-4256-AA45-072A0A660003Q34630641-045F1362-55EA-42D5-A993-28901A823BF9Q34789195-2DAFA778-6FBB-4518-AD27-6FAB4A90C3FCQ34950552-0B74F9CF-37D8-4818-B679-0D3161E14CA0Q35065882-4B107DAE-DBC3-431B-B85A-ADC3D5387D6BQ35681664-46EA0E95-A6B9-4140-8C81-B8A6B6FCF362Q35895632-00D15A10-444E-487C-A6EF-91D6535E13CAQ35970046-FA36CBE9-2567-4E67-AA06-FCBCBB37B6D0Q36090279-1783086E-9971-4AA5-AB90-F3B21FE3B998Q36354205-5DF36C2F-D505-45E4-A5E9-79D8F1D4CA0BQ36365583-B8D9934D-7C62-4822-BDEB-3F59CC58A3ABQ36707147-6BFB518C-8084-481D-8BE1-AE3C3DC0CFA5Q36707183-419B90A1-DA96-4330-825F-D2D2E9D4DBDAQ36781342-65CA6DEC-CED5-4D9D-A433-BEAADDBAFFBAQ36964382-8B21EB90-25CA-44D7-B98A-3C9D3233670EQ37366679-4FE325E5-2737-40A2-B5D2-72EFDF73A030Q37466204-7AC8A0C3-786F-46E0-AFEA-BB0D0BF3B8ECQ37479820-34203739-093A-40EE-8020-2978D321E808Q37619566-BC0C6941-F5D5-4B57-A092-F8767EAF013BQ37724245-5D26262D-67ED-4B21-88DD-05FAAE49A4B2Q37936459-E62DC4DC-4C9C-49CA-A6D6-5F9BC3613ECAQ38025152-EA520250-BCA4-4DAC-A29E-95B008847277Q38074446-0CD79F4A-F0AC-4741-BA9F-9FF27838F93BQ38095599-DA7D8C98-08A9-4BE2-A761-3A54D4EE19E0Q38119243-C0411DA1-A8BC-41E0-8100-A9E66960E96FQ38130246-D8993583-9B6F-43DE-B709-C8672490C3D9Q38166016-0E8862B8-AD86-4312-BAEA-2E77C263F917Q38171373-6BD35F5D-40FD-4941-93C7-F3BF16FAD1F6
P2860
Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Overall and cancer related mor ...... s: retrospective cohort study.
@ast
Overall and cancer related mor ...... s: retrospective cohort study.
@en
type
label
Overall and cancer related mor ...... s: retrospective cohort study.
@ast
Overall and cancer related mor ...... s: retrospective cohort study.
@en
prefLabel
Overall and cancer related mor ...... s: retrospective cohort study.
@ast
Overall and cancer related mor ...... s: retrospective cohort study.
@en
P2093
P2860
P356
P1433
P1476
Overall and cancer related mor ...... s: retrospective cohort study.
@en
P2093
Asaf Hanish
C Stephen Foster
Craig W Newcomb
Douglas A Jabs
Ebenezer Daniel
Eric B Suhler
James P Dunn
James T Rosenbaum
Jennifer E Thorne
John H Kempen
P2860
P356
10.1136/BMJ.B2480
P407
P577
2009-07-03T00:00:00Z